Incyte Corporation
Incyte Corporation is listed as the manufacturer on 3 FDA drug label records covering 2 distinct active ingredients predominantly human prescription drug products.
About Incyte Corporation
Incyte Corporation is named as the labeler on 3 FDA drug label records. Its catalogue spans 2 distinct active ingredients, led by RUXOLITINIB, PEMIGATINIB. Most of these labels are human prescription drug products. Labelling across this portfolio most often references: pediatric patients, graft-versus-host disease, jakafi jakafi, treatment adults, years age, inhibitor indicated, fibroblast growth, factor receptor. Use the table below to identify a specific product, then open it for full indications, dosage and warnings as filed with the FDA.
Active ingredients in this portfolio
| Active ingredient | Products |
|---|---|
| RUXOLITINIB | 2 |
| PEMIGATINIB | 1 |
Dosage forms and routes
| Dosage form | Products | Route | Products |
|---|---|---|---|
| — | — | ORAL | 2 |
| — | — | TOPICAL | 1 |
| — | — | — | — |
| — | — | — | — |
| — | — | — | — |
| — | — | — | — |
FDA drug products from Incyte Corporation
Frequently asked questions
How many FDA drug products does Incyte Corporation make?
3 FDA drug label records name Incyte Corporation as the manufacturer, covering 2 distinct active ingredients.
What active ingredients does Incyte Corporation produce?
The most frequent active ingredients in this portfolio are RUXOLITINIB, PEMIGATINIB.
Are Incyte Corporation products prescription or over-the-counter?
The largest share of this company’s labels are human prescription drug products; check each product page for its own marketing status.
Does this page list prices or where to buy?
No. This is a labelling reference built from FDA data. It does not sell, price or recommend any medicine.
Labelling data reproduced from FDA Structured Product Labelling for identification only. This site does not sell, price or recommend any medicine.